UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044805
Receipt number R000051172
Scientific Title Clinical EEG studies of spontaneous EEG and auditory steady-state responses in schizophrenia, mood disorders, autism spectrum disorders, epilepsy, and healthy control
Date of disclosure of the study information 2021/07/12
Last modified on 2021/07/08 23:08:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical EEG studies of spontaneous EEG and auditory steady-state responses in schizophrenia, mood disorders, autism spectrum disorders, epilepsy, and healthy control

Acronym

Clinical EEG research for psychiatric disorders

Scientific Title

Clinical EEG studies of spontaneous EEG and auditory steady-state responses in schizophrenia, mood disorders, autism spectrum disorders, epilepsy, and healthy control

Scientific Title:Acronym

Clinical EEG research for psychiatric disorders

Region

Japan


Condition

Condition

schizophrenia, mood disorders, autism spectrum disorders, epilepsy, and healthy control

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to detect neurophysiological biomarkers for various psychiatric disorders, such as schizophrenia, mood disorder, autism spectrum disorder, and epilepsy by analyzing spontaneous EEG activity and auditory steady-state response.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Power spectral density for each EEG electrode and coherence between electrodes

Key secondary outcomes

Gamma-band power and phase locking factor for each EEG electrode in auditory steady-state response


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

spontaneous activity, auditory steady-state response

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Healthy subjects group
(1) Males and females aged 20-65 years

Patient group
(1) Males and females aged 20-65 years
(2) Patients with schizophrenia, bipolar disorder, major depressive disorder, and autism spectrum disorder
(3) Diagnosis will be conducted based on DSM-V
(4) Two or more psychiatrists will conduct a diagnosis of each patient

Key exclusion criteria

Normal group
(1) History of neurological disease or severe head injury
(2) History of electroconvulsive therapy
(3) History of alcohol or drug abuse within the past 5 years
(4) When the participant is suspected of having a mental illness in a structured interview (SCID non-patient edition), or, when a first-degree close relative (parent, sibling, child) has a mental illness
(5) Hearing impairment

Patient group
(1) History of Neurological disorders (excluding epilepsy in the epilepsy group) or severe head trauma
(2) History of electroconvulsive therapy
(3) History of alcohol abuse or drug abuse within the past 5 years
(4) Hearing impairment
(5) When researcher judge that the patient is ineligible to participate this study

Target sample size

1050


Research contact person

Name of lead principal investigator

1st name Toshiaki
Middle name
Last name Onitsuka

Organization

Kyushu University

Division name

Department of Neuroimaging Psychiatry, Graduate School of Medical Sciences

Zip code

812-8582

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka

TEL

092-642-5641

Email

nouseiri.ku@gmail.com


Public contact

Name of contact person

1st name Toshiaki
Middle name
Last name Onitsuka

Organization

Kyushu University

Division name

Department of Neuroimaging Psychiatry, Graduate School of Medical Sciences

Zip code

812-8582

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka

TEL

092-642-5641

Homepage URL


Email

nouseiri.ku@gmail.com


Sponsor or person

Institute

Kyushu University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency of Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyushu University

Address

3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka

Tel

092-642-5082

Email

byskenkyu@jimu.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 06 Month 01 Day

Date of IRB

2020 Year 05 Month 29 Day

Anticipated trial start date

2020 Year 06 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 07 Month 08 Day

Last modified on

2021 Year 07 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051172


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name